The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preoperative window-of-opportunity (WOO) study of dacomitinib (Dac) in patients (Pts) with resectable oral cavity squamous cell carcinoma (OCC): Generation of a gene expression signature (DGS) as a predictor of Dac activity.
Irene Brana
No relevant relationships to disclose
Desmond She
No relevant relationships to disclose
Nicole Grace Chau
No relevant relationships to disclose
Nhu-An Pham
No relevant relationships to disclose
Lucia Kim
No relevant relationships to disclose
Shingo Sakashita
No relevant relationships to disclose
Christine Ng
No relevant relationships to disclose
ChangQi Zhu
No relevant relationships to disclose
Albiruni R. A. Razak
Research Funding - Pfizer
Eric Chen
No relevant relationships to disclose
Lisa Wang
No relevant relationships to disclose
Bayardo Perz-Ordonez
No relevant relationships to disclose
Eric Winquist
No relevant relationships to disclose
Sebastien J. Hotte
No relevant relationships to disclose
Ming-Sound Tsao
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer
Research Funding - Pfizer
Lillian L. Siu
Research Funding - Pfizer